Health Care & Life Sciences » Pharmaceuticals | Chengdu Kanghong Pharmaceutical Group Co. Ltd.

Chengdu Kanghong Pharmaceutical Group Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
319,130.40
276,465.50
396,986.50
500,119.70
644,199.00
694,943.80
Depreciation, Depletion & Amortization
60,216.80
69,604.90
71,647.80
71,875.40
72,751.50
80,850.30
Other Funds
38,578.20
55,399.40
586,016.30
187,825.40
186.70
2,604.20
Funds from Operations
327,127.70
346,862.40
456,152.40
596,814.40
811,283.40
760,371.10
Changes in Working Capital
7,659.10
44,286.20
37,054.10
265,338.10
13,813.10
380,142.30
Net Operating Cash Flow
334,786.80
302,576.20
493,206.40
862,152.50
797,470.30
380,228.80
Capital Expenditures
77,157.40
90,269.50
115,828.10
170,226.20
312,881.80
Sale of Fixed Assets & Businesses
7.90
385.50
125.70
268.30
51.80
Purchase/Sale of Investments
738,300.00
2,254,105.00
152,412.60
122,919.50
259,010.30
Net Investing Cash Flow
1,775.80
45,623.00
273,128.30
265,969.10
45,210.20
Cash Dividends Paid - Total
-
-
60,000.00
89,875.70
100,944.20
Issuance/Reduction of Debt, Net
35,000.00
2,000.00
5,000.00
-
-
Net Financing Cash Flow
73,578.20
57,399.40
521,016.30
97,949.70
122,562.60
Net Change in Cash
262,220.80
199,491.50
742,197.10
698,466.50
715,338.70
Free Cash Flow
257,629.40
212,306.70
377,378.30
691,926.30
484,588.50
Deferred Taxes & Investment Tax Credit
58.40
557.50
13,539.40
19,752.20
21,712.00
18,027.20
Other Sources
817,228.30
2,302,174.20
18,886.40
33,750.20
99,029.90
Change in Capital Stock
-
-
-
-
21,805.10
Exchange Rate Effect
763.60
62.30
1,102.70
4,333.50
4,779.10
Other Uses
3.00
3,808.20
23,899.60
6,842.00
-

About Chengdu Kanghong Pharmaceutical Group Co.

View Profile
Address
No. 36 Shuxi Road
Chengdu Sichuan 610036
China
Employees -
Website http://www.cnkh.com
Updated 07/08/2019
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, manufacture and distribution of biological products, traditional Chinese medicines, and chemical drugs. Its products include conbercept ophthalmic injection, songling xuemaikang jiaonang, shugan jieyu jiaonang, kenuoxin jiaonang, danshu jiaonang, yiqing jiaonang, venlafaxine hydrochloride capsules and sustained-release tablets, aripiprazole tablets and orally disintergrating tablets, mosapride citrate dispersible tablets, and dexzopiclone tablet. The company was founded on October 3, 1996 and is headquartered in Chengdu, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.